Comparison between Interiors & More IPO and Zenith Drugs IPO.
Interiors & More IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Bookbuilding proposed to list at NSE SME.
| Interiors & More IPO | Zenith Drugs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Gretex Corporate Services Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Interiors & More IPO is up to ₹39.89 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹33.94 Cr. The final issue price of Interiors & More IPO is ₹227.00 per share and of Zenith Drugs IPO is ₹79.00 per share.
| Interiors & More IPO | Zenith Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹216.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹227.00 per share | ₹79.00 per share |
| Issue Price (Final) | ₹227.00 per share | ₹79.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 600 shares | 1600 shares |
| Fresh Issue Size | 17,57,400 shares | 42,96,000 shares |
| Fresh Issue Size (Amount) | up to ₹39.89 Cr | up to ₹33.94 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,57,400 shares | 42,96,000 shares |
| Issue Size Total (Amount) | up to ₹39.89 Cr | up to ₹33.94 Cr |
Interiors & More IPO opens on Feb 15, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Interiors & More IPO and Zenith Drugs IPO is Feb 20, 2024, and Feb 22, 2024, respectively.
| Interiors & More IPO | Zenith Drugs IPO | |
|---|---|---|
| Anchor Bid Date | Feb 14, 2024 | Feb 16, 2024 |
| Issue Open | Feb 15, 2024 | Feb 19, 2024 |
| Issue Close | Feb 20, 2024 | Feb 22, 2024 |
| Basis Of Allotment (Tentative) | Feb 21, 2024 | Feb 23, 2024 |
| Initiation of Refunds (Tentative) | Feb 22, 2024 | Feb 26, 2024 |
| Credit of Share (Tentative) | Feb 22, 2024 | Feb 26, 2024 |
| Listing date (Tentative) | Feb 23, 2024 | Feb 27, 2024 |
| Anchor Lockin End date 1 | Mar 22, 2024 | Mar 24, 2024 |
| Anchor Lockin End date 2 | May 21, 2024 | May 23, 2024 |
Interiors & More IPO P/E ratio is 19.7, as compared to Zenith Drugs IPO P/E ratio of 18.4.
| Interiors & More IPO | Zenith Drugs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 95.08 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.93 | 69.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 19.7 | 18.4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹158.80 Cr. | ₹135.48 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 84.68% | 35.13% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 75.58% | 37.29% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.45 | 1.51 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹11.52 | ₹4.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 59.57% | 29.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Interiors & More IPO Retail Individual Investors (RII) are offered 6,15,600 shares while in Zenith Drugs IPO retail investors are offered 6,15,600 shares. Qualified Institutional Buyers (QIB) are offered 3,51,600 shares in Interiors & More IPO and 8,59,200 shares in Zenith Drugs IPO.
| Interiors & More IPO | Zenith Drugs IPO | |
|---|---|---|
| Anchor Investor Reservation | 5,26,200 shares | 12,88,000 shares |
| Market Maker Reservation | 93,000 shares | 8,52,800 shares |
| QIB | 3,51,600 shares | 8,59,200 shares |
| NII | 2,64,000 shares | 6,44,800 shares |
| RII | 6,15,600 shares | 15,04,000 shares |
| Employee | ||
| Others | ||
| Total | 17,57,400 shares | 42,96,000 shares |
Interiors & More IPO subscribed 11.22x in total, whereas Zenith Drugs IPO subscribed 179.18x.
| Interiors & More IPO | Zenith Drugs IPO | |
|---|---|---|
| QIB (times) | 3.54x | 106.72x |
| NII (times) | 30.32x | 368.77x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 7.41x | 139.28x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 11.22x | 179.18x |
